Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy.
暂无分享,去创建一个
J. Mazières | B. Besse | L. Mezquita | T. Filleron | L. Hendriks | M. Sabatier | R. Ferrara | C. Lefebvre | R. Veillon | C. Raherisson | A. Dingemans | F. Puisset | E. Martin